| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol transfer activity | 1.63e-04 | 11 | 35 | 2 | GO:0008526 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 5.56e-04 | 20 | 35 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | K48-linked deubiquitinase activity | 6.14e-04 | 21 | 35 | 2 | GO:1990380 | |
| GeneOntologyMolecularFunction | phospholipid transfer activity | 9.45e-04 | 26 | 35 | 2 | GO:0120014 | |
| GeneOntologyBiologicalProcess | cranial skeletal system development | 1.22e-05 | 84 | 35 | 4 | GO:1904888 | |
| MousePheno | abnormal neural crest cell migration | 5.10e-05 | 34 | 30 | 3 | MP:0002950 | |
| MousePheno | abnormal head mesenchyme morphology | 5.57e-05 | 35 | 30 | 3 | MP:0011260 | |
| MousePheno | abnormal neural crest cell physiology | 1.04e-04 | 43 | 30 | 3 | MP:0012745 | |
| Domain | IP_trans | 3.60e-05 | 5 | 36 | 2 | PF02121 | |
| Domain | LNS2 | 5.39e-05 | 6 | 36 | 2 | PF08235 | |
| Domain | DDHD_dom | 5.39e-05 | 6 | 36 | 2 | IPR004177 | |
| Domain | LNS2 | 5.39e-05 | 6 | 36 | 2 | IPR013209 | |
| Domain | PI_transfer | 5.39e-05 | 6 | 36 | 2 | IPR001666 | |
| Domain | LNS2 | 5.39e-05 | 6 | 36 | 2 | SM00775 | |
| Domain | DDHD | 5.39e-05 | 6 | 36 | 2 | SM01127 | |
| Domain | DDHD | 5.39e-05 | 6 | 36 | 2 | PF02862 | |
| Domain | DDHD | 5.39e-05 | 6 | 36 | 2 | PS51043 | |
| Domain | LNS2/PITP | 5.39e-05 | 6 | 36 | 2 | IPR031315 | |
| Domain | - | 2.53e-04 | 64 | 36 | 3 | 3.40.50.1000 | |
| Domain | HAD-like_dom | 4.70e-04 | 79 | 36 | 3 | IPR023214 | |
| Domain | - | 8.91e-04 | 23 | 36 | 2 | 3.30.530.20 | |
| Domain | START-like_dom | 8.91e-04 | 23 | 36 | 2 | IPR023393 | |
| Domain | S100_CABP | 1.23e-03 | 27 | 36 | 2 | PS00303 | |
| Domain | S_100 | 1.23e-03 | 27 | 36 | 2 | PF01023 | |
| Domain | S100_Ca-bd_sub | 1.32e-03 | 28 | 36 | 2 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 1.32e-03 | 28 | 36 | 2 | IPR001751 | |
| Domain | S_100 | 1.32e-03 | 28 | 36 | 2 | SM01394 | |
| Domain | UBA-like | 6.76e-03 | 64 | 36 | 2 | IPR009060 | |
| Domain | USP_CS | 7.17e-03 | 66 | 36 | 2 | IPR018200 | |
| Domain | USP_1 | 8.03e-03 | 70 | 36 | 2 | PS00972 | |
| Domain | UCH | 8.26e-03 | 71 | 36 | 2 | PF00443 | |
| Domain | USP_2 | 8.26e-03 | 71 | 36 | 2 | PS00973 | |
| Domain | USP_3 | 8.48e-03 | 72 | 36 | 2 | PS50235 | |
| Domain | USP_dom | 8.48e-03 | 72 | 36 | 2 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 8.48e-03 | 72 | 36 | 2 | IPR001394 | |
| Pathway | REACTOME_SYNTHESIS_OF_PI | 4.97e-05 | 5 | 32 | 2 | MM14587 | |
| Pathway | REACTOME_SYNTHESIS_OF_PI | 4.97e-05 | 5 | 32 | 2 | M26962 | |
| Pubmed | NT5C2 USP7 ZNF462 SOX10 HNRNPUL1 WDR1 FLG2 UBAP2L SEC24B SORL1 | 1.27e-06 | 1429 | 36 | 10 | 35140242 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 15627748 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12562526 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 32601462 | ||
| Pubmed | Pitpnm1 is expressed in hair cells during development but is not required for hearing. | 3.12e-06 | 3 | 36 | 2 | 23820044 | |
| Pubmed | Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease. | 3.12e-06 | 3 | 36 | 2 | 27444016 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 10022914 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 11104777 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 31594866 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 27501351 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 15815685 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 35636624 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 24270891 | ||
| Pubmed | Plasticity of neural crest-placode interaction in the developing visceral nervous system. | 2.91e-05 | 8 | 36 | 2 | 21674689 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 36941270 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 15367676 | ||
| Pubmed | USP11 Is a Negative Regulator to γH2AX Ubiquitylation by RNF8/RNF168. | 2.91e-05 | 8 | 36 | 2 | 26507658 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 3.44e-05 | 607 | 36 | 6 | 39147351 | |
| Pubmed | 3.68e-05 | 916 | 36 | 7 | 32203420 | ||
| Pubmed | Hoxa1 and Hoxb1 are required for pharyngeal arch artery development. | 3.73e-05 | 9 | 36 | 2 | 27956219 | |
| Pubmed | Identification and validation of selective deubiquitinase inhibitors. | 3.73e-05 | 9 | 36 | 2 | 34129829 | |
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 28973533 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 22195557 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 4.16e-05 | 934 | 36 | 7 | 33916271 | |
| Pubmed | Lack of in vivo functional compensation between Pax family groups II and III in rodents. | 4.66e-05 | 10 | 36 | 2 | 21512107 | |
| Pubmed | 5.05e-05 | 963 | 36 | 7 | 28671696 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 29604273 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 7.83e-05 | 220 | 36 | 4 | 35785414 | |
| Pubmed | 7.92e-05 | 80 | 36 | 3 | 16094384 | ||
| Pubmed | 9.41e-05 | 14 | 36 | 2 | 22653443 | ||
| Pubmed | 9.41e-05 | 14 | 36 | 2 | 20171203 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.05e-04 | 1082 | 36 | 7 | 38697112 | |
| Pubmed | Deubiquitinating enzymes: a new class of biological regulators. | 1.08e-04 | 15 | 36 | 2 | 9827704 | |
| Pubmed | 1.08e-04 | 15 | 36 | 2 | 11532923 | ||
| Pubmed | Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. | 1.08e-04 | 15 | 36 | 2 | 24482476 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 1.09e-04 | 462 | 36 | 5 | 31138677 | |
| Pubmed | USP25 regulates Wnt signaling by controlling the stability of tankyrases. | 1.24e-04 | 16 | 36 | 2 | 28619731 | |
| Pubmed | A strategy for modulation of enzymes in the ubiquitin system. | 1.40e-04 | 17 | 36 | 2 | 23287719 | |
| Pubmed | Sox10 cooperates with the mediator subunit 12 during terminal differentiation of myelinating glia. | 1.58e-04 | 18 | 36 | 2 | 23575864 | |
| Pubmed | Ablation of Ezh2 in neural crest cells leads to aberrant enteric nervous system development in mice. | 1.96e-04 | 20 | 36 | 2 | 30169530 | |
| Pubmed | 1.96e-04 | 20 | 36 | 2 | 21068328 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.00e-04 | 281 | 36 | 4 | 28706196 | |
| Pubmed | 2.38e-04 | 22 | 36 | 2 | 34799561 | ||
| Pubmed | OTUB1 modulates c-IAP1 stability to regulate signalling pathways. | 2.83e-04 | 24 | 36 | 2 | 23524849 | |
| Pubmed | 3.01e-04 | 1285 | 36 | 7 | 35914814 | ||
| Pubmed | 3.40e-04 | 131 | 36 | 3 | 34551306 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 3.56e-04 | 1321 | 36 | 7 | 27173435 | |
| Pubmed | 3.87e-04 | 28 | 36 | 2 | 20534741 | ||
| Pubmed | Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. | 3.87e-04 | 28 | 36 | 2 | 22118674 | |
| Pubmed | 3.87e-04 | 28 | 36 | 2 | 24861553 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 4.12e-04 | 1353 | 36 | 7 | 29467282 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 4.32e-04 | 344 | 36 | 4 | 30333137 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | 4.35e-04 | 624 | 36 | 5 | 33729478 | |
| Pubmed | 4.46e-04 | 347 | 36 | 4 | 17114649 | ||
| Pubmed | 4.58e-04 | 145 | 36 | 3 | 28846114 | ||
| Pubmed | 5.07e-04 | 32 | 36 | 2 | 19542561 | ||
| Pubmed | 5.26e-04 | 152 | 36 | 3 | 16009940 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 5.32e-04 | 1005 | 36 | 6 | 19615732 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 5.38e-04 | 1415 | 36 | 7 | 28515276 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 5.46e-04 | 154 | 36 | 3 | 16055720 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 5.61e-04 | 1425 | 36 | 7 | 30948266 | |
| Pubmed | 5.62e-04 | 660 | 36 | 5 | 32780723 | ||
| Pubmed | 5.67e-04 | 156 | 36 | 3 | 29961565 | ||
| Pubmed | 5.76e-04 | 1431 | 36 | 7 | 37142655 | ||
| Pubmed | 5.91e-04 | 374 | 36 | 4 | 23824909 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 6.35e-04 | 1455 | 36 | 7 | 22863883 | |
| Pubmed | 6.42e-04 | 36 | 36 | 2 | 22626734 | ||
| Pubmed | 6.42e-04 | 36 | 36 | 2 | 15717329 | ||
| Pubmed | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. | 6.78e-04 | 37 | 36 | 2 | 24162737 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 7.09e-04 | 695 | 36 | 5 | 23602568 | |
| Pubmed | 7.38e-04 | 397 | 36 | 4 | 21319273 | ||
| Pubmed | 8.10e-04 | 407 | 36 | 4 | 12693553 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 8.45e-04 | 179 | 36 | 3 | 36261009 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 8.86e-04 | 182 | 36 | 3 | 31067453 | |
| Pubmed | 9.59e-04 | 44 | 36 | 2 | 20200978 | ||
| Cytoband | 1q21.3 | 1.08e-04 | 117 | 36 | 3 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 2.79e-04 | 404 | 36 | 4 | chr1q21 | |
| GeneFamily | Phosphatidylinositol transfer proteins | 3.71e-05 | 6 | 29 | 2 | 1151 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 5.19e-05 | 7 | 29 | 2 | 1350 | |
| GeneFamily | Ubiquitin specific peptidases | 3.63e-03 | 56 | 29 | 2 | 366 | |
| Disease | smoking status measurement | 7.84e-06 | 1160 | 36 | 9 | EFO_0006527 | |
| Disease | Paroxysmal atrial fibrillation | 3.88e-05 | 156 | 36 | 4 | C0235480 | |
| Disease | Persistent atrial fibrillation | 3.88e-05 | 156 | 36 | 4 | C2585653 | |
| Disease | familial atrial fibrillation | 3.88e-05 | 156 | 36 | 4 | C3468561 | |
| Disease | Atrial Fibrillation | 4.28e-05 | 160 | 36 | 4 | C0004238 | |
| Disease | Mental deterioration | 5.18e-05 | 9 | 36 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 5.18e-05 | 9 | 36 | 2 | C1270972 | |
| Disease | Impaired cognition | 1.30e-04 | 14 | 36 | 2 | C0338656 | |
| Disease | Alzheimer disease, educational attainment | 2.29e-04 | 247 | 36 | 4 | EFO_0011015, MONDO_0004975 | |
| Disease | late-onset Alzheimers disease | 4.31e-04 | 292 | 36 | 4 | EFO_1001870 | |
| Disease | smoking behavior, body mass index | 4.56e-04 | 123 | 36 | 3 | EFO_0004318, EFO_0004340 | |
| Disease | Hirschsprung Disease | 6.58e-04 | 31 | 36 | 2 | C0019569 | |
| Disease | smoking behavior | 7.71e-04 | 341 | 36 | 4 | EFO_0004318 | |
| Disease | prostate cancer (is_marker_for) | 9.11e-04 | 156 | 36 | 3 | DOID:10283 (is_marker_for) | |
| Disease | atrial fibrillation | 1.05e-03 | 371 | 36 | 4 | EFO_0000275 | |
| Disease | Congenital Heart Defects | 1.33e-03 | 44 | 36 | 2 | C0018798 | |
| Disease | microglial activation measurement | 2.37e-03 | 59 | 36 | 2 | EFO_0010940 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TYTGPLQHGIVYSGG | 316 | P49902 | |
| GGEHCYYQGHIRGNP | 131 | Q9P0K1 | |
| GYTNYGSFGHLHGHP | 411 | P78411 | |
| HGSYGPAEYDYGHTG | 2346 | Q5D862 | |
| SGTHTHSGPAGYFQY | 191 | Q9NR71 | |
| GVFTGPGGHSYQGHW | 51 | Q96JJ6 | |
| TLGHGNGGTVYKAYH | 171 | Q13163 | |
| SGYVHQQAPTYGHGL | 1996 | Q93074 | |
| VSPSHGGQYRCYGAH | 286 | Q6PI73 | |
| HQGYAGGAVGSPQYI | 146 | P49639 | |
| GGAVGSPQYIHHSYG | 151 | P49639 | |
| GPGGSGQYTHKVYHV | 51 | Q9BZ72 | |
| GQGGTFRYTFHGDPH | 81 | Q9UDY4 | |
| EPHYGHAGTVYGGVM | 476 | Q9P2N7 | |
| NGHYIGGHVSLYLPG | 1856 | P17927 | |
| PGIPHFGTGGYQAAH | 181 | Q9H227 | |
| GHQGALYLYHGTQSG | 576 | O75578 | |
| GYGLHHQNYIAPSGH | 56 | O95487 | |
| YHASGHSVAYKPGGF | 211 | P56856 | |
| HHSLGGQYGVQGFPT | 86 | Q15084 | |
| HAEPGGYSGPDGHYA | 86 | Q9BUJ2 | |
| RNYGHFPGINSHYLG | 581 | Q9NP80 | |
| GPHYYTWGDHGGIIT | 536 | Q92673 | |
| AGAYHARHAAAYPGG | 351 | O00358 | |
| HYQVSGYPGSHGITA | 741 | Q05397 | |
| SQHYPHRGSGGVHQY | 1411 | Q9C0A6 | |
| NGGKSYIYSGSHDGH | 331 | O75083 | |
| GPGGSGQYTHKVYHV | 51 | O00562 | |
| YYLSGGFHPVGFHVV | 96 | Q5T4D3 | |
| QPSGYGSHGYNTGVS | 956 | Q14157 | |
| GGLVPLHNACSYGHY | 401 | O95271 | |
| GGLVPLHNACSYGHY | 716 | O95271 | |
| HPGHVSSYSAAGYGL | 306 | P56693 | |
| GQYGGHHQGMPGYLP | 426 | O43670 | |
| NATSLGTGGYYGHSP | 76 | Q96JM2 | |
| YGHSPGYYGQHIAAN | 86 | Q96JM2 | |
| SYHYGQPDGQGQSSH | 496 | Q6XPR3 | |
| HGGHYVVYLNPKGDG | 461 | Q93009 | |
| VSNHYGGLDGGHYTA | 1056 | P40818 |